Breaking Studies News Today

BALTIMORE — Patients with heavy menstrual bleeding who received the levonorgestrel 52 mg intrauterine device experienced significant and rapid decreases in uterine bleeding after placement, a researcher reported here.Blood loss was reduced by more than 90% over 6 months after placement of the Liletta levonorgestrel-releasing intrauterine system (AbbVie/Medicines360) compared with baseline

BALTIMORE — A one-time dose of off-label cabergoline after second-trimester abortion or pregnancy loss was effective for preventing symptomatic breast engorgement, according to data presented at the ACOG Annual Clinical & Scientific Meeting.“Breast engorgement is common after second-trimester abortion. The severity of bother is underappreciated and undertreated by most

SCAI 2021 Late-breaking Clinical Study Results SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI. April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from the Society for Cardiovascular Angiograph...